article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Streamlining Center of Excellence Provider Network Development in Record Time

Clarify Health

They often play a critical role in advancing medical knowledge and improving patient care in specialized areas of healthcare. CoEs can be established by a variety of entities, including healthcare organizations, medical institutions, government agencies, and sometimes private entities. Feeling inspired?

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

For that reason, it is also essential to be aware of the most prominent global research organizations that offer vital support with their specialized clinical trial solutions. The company develops special testing operations such as HIV genotyping, oncology testing, phenotyping, clinical trials, and diagnostic genetics.

article thumbnail

The future of the IP legal profession: new strategies, new technologies

Clarivate

Entering sensitive information into tools like ChatGPT could present risks, requiring careful attention to policies governing use of AI tools. For more resources on AI in IP view our webinar and special report: Webinar: Is AI the dawn of a new era for IP practitioners? Special Report: Redefining Artificial Intelligence.

article thumbnail

Payment delays for pharma MSMEs are a significant problem

eMediWrite

SMEs are also at a disadvantage when compared to their larger counterparts due to delayed payments, which limits their capacity for effective market competition. Government initiatives are crucial for fostering change. This limits their ability to grow and stifles the creation of jobs.

Pharma 52
article thumbnail

You get what you agree to, at least when it comes to the money under VPAS

pharmaphorum

Predictable for government. The 2019 VPAS deal was struck as a negotiation between DHSC, NHS England, the devolved nations, as well as others on the side of the government and industry body, the ABPI. The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. More transparency needed.